Clear Search sequence regions

  • alvocidib (1)
  • antibiotics (2)
  • cancer (6)
  • cell (2)
  • cell growth (1)
  • chromatin (3)
  • dna (1)
  • drug antitumor (1)
  • fk 973 (1)
  • flavonoids (2)
  • fr 900482 (1)
  • gene (2)
  • HMGA1 (8)
  • hmga1a protein (2)
  • hmga1b protein (2)
  • humans (1)
  • impairs (1)
  • mice (1)
  • neoplasm proteins (2)
  • oxazines (2)
  • patients (1)
  • piperidines (2)
  • research (2)
  • rna (4)
  • short hairpin rna (1)
  • stem (1)
  • stem cells (1)
  • switch off (1)
  • therapies (1)
  • Sizes of these terms reflect their relevance to your search.

    Emerging evidence demonstrates that the high mobility group A1 (HMGA1) chromatin remodeling protein is a key molecular switch required by cancer cells for tumor progression and a poorly differentiated, stem-like state. Because the HMGA1 gene and proteins are expressed at high levels in all aggressive tumors studied to date, research is needed to determine how to 'turn off' this master regulatory switch in cancer. In this review, we describe prior studies that underscore the central role of HMGA1 in refractory cancers and we discuss approaches to target HMGA1 in cancer therapy. Given the widespread overexpression of HMGA1 in diverse, aggressive tumors, further research to develop technology to target HMGA1 holds immense promise as potent anticancer therapy. Previous work in preclinical models indicates that delivery of short hairpin RNA or interfering RNA molecules to 'switch off' HMGA1 expression dramatically impairs cancer cell growth and tumor progression. The advent of nanoparticle technology to systemically deliver DNA or RNA molecules to tumors brings this approach even closer to clinical applications, although further efforts are needed to translate these advances into therapies for cancer patients.


    Tait H Huso, Linda M S Resar. The high mobility group A1 molecular switch: turning on cancer - can we turn it off? Expert opinion on therapeutic targets. 2014 May;18(5):541-53

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 24684280

    View Full Text